Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging and Biomarkers (IMPROD)

IMPROD clinical trial ( Identifier NCT01864135 ) evaluated the role of prebiopsy MRI and biomarkers for the detection of prostate cancer in patients with a clinical suspicion of prostate cancer. This site provides free access to all datasets collected during the trial and follow up.

Log in